Hypertension in Pregnancy: A Diagnostic and Therapeutic Overview
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F23%3A10001165" target="_blank" >RIV/00064190:_____/23:10001165 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/23:10466005
Result on the web
<a href="https://link.springer.com/article/10.1007/s40292-023-00582-5" target="_blank" >https://link.springer.com/article/10.1007/s40292-023-00582-5</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s40292-023-00582-5" target="_blank" >10.1007/s40292-023-00582-5</a>
Alternative languages
Result language
angličtina
Original language name
Hypertension in Pregnancy: A Diagnostic and Therapeutic Overview
Original language description
Hypertensive disorders in pregnancy are associated with increased risk of maternal, fetal, and neonatal morbidity and mortality. It is important to distinguish between pre-existing (chronic) hypertension and gestational hypertension, developing after 20 weeks of gestation and usually resolving within 6 weeks postpartum. There is a consensus that systolic blood pressure GREATER-THAN OR EQUAL TO 170 or diastolic blood pressure GREATER-THAN OR EQUAL TO 110 mmHg is an emergency and hospitalization is indicated. The selection of the antihypertensive drug and its route of administration depend on the expected time of delivery. The current European guidelines recommend initiating drug treatment in pregnant women with persistent elevation of blood pressure GREATER-THAN OR EQUAL TO 150/95 mmHg and at values > 140/90 mmHg in women with gestational hypertension (with or without proteinuria), with pre-existing hypertension with the superimposition of gestational hypertension, and with hypertension with subclinical organ damage or symptoms at any time during pregnancy. Methyldopa, labetalol, and calcium antagonists (the most data are available for nifedipine) are the drugs of choice. The results of the CHIPS and CHAP studies are likely to reduce the threshold for initiating treatment. Women with a history of hypertensive disorders in pregnancy, particularly those with pre-eclampsia, are at high risk of developing cardiovascular disease later in life. Obstetric history should become a part of the cardiovascular risk assessment in women. (C) 2023, The Author(s).
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
High Blood Pressure and Cardiovascular Prevention
ISSN
1120-9879
e-ISSN
1179-1985
Volume of the periodical
30
Issue of the periodical within the volume
4
Country of publishing house
NZ - NEW ZEALAND
Number of pages
15
Pages from-to
289-303
UT code for WoS article
001004835200001
EID of the result in the Scopus database
2-s2.0-85161665253